Imiquimod Cream
Indicated to target actinic keratosis and genital warts and to support the immune response to eradicate abnormal skin cells.
Strengths: 5%
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Aldara
- Therapeutic class
Immune Response Modifier
- Pharmacological class
Imidazoquinolone
- Known off-label uses
superficial basal cell carcinoma
- Contraindications
hypersensitivity to imiquimod
- Minor side effects
erythema; itching; scabbing
- Moderate side effects
excoriation; oedema; skin ulceration
- Dosage forms
Cream
- Administration route
Cutaneous use
- Prescription status
POM
- Manufacturer
Meda Pharmaceuticals
- Onset Time
weeks
- Duration
weeks
- Storage instructions
Store below 25°C, do not freeze.
- Age restrictions
Adults.
- Pregnancy and breastfeeding
Pregnancy: Use only if necessary. Breastfeeding: Use with caution.
Precautions and warnings
avoid sunlight or sunbeds during use; apply only to affected areas; wash hands thoroughly after application
Serious side effects
severe dermatitis — requires immediate medical attention; systemic flu-like symptoms — requires immediate medical attention
Patient summary
Indicated to target actinic keratosis and genital warts and to support the immune response to eradicate abnormal skin cells.
Mechanism of action
Imiquimod is an immune response modifier it induces cytokines including interferon-alpha, which assists the immune system in targeting viral infections and malignant skin cells.
Imiquimod Cream
Indicated to target actinic keratosis and genital warts and to support the immune response to eradicate abnormal skin cells.
Editorial Notes
- Active ingredient(s): Imiquimod
- Listed indication(s): Actinic Keratosis, Genital Warts
Available option
- 9 tubes - 5 %1142-5-pct-13532